HolderBook

KVP Capital Advisors, LP

Reported holdings as of Q2 2026, from 3 quarterly filings.

CIK
1858198
Reported value
$136.2M
Positions
35
Top 10 weight
57.4%
Filed
2026-08-13
Days after quarter end
44

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
PRAXIS PRECISION MEDICINES IPRAX$14.4M42,90010.54%+0.22pp3qHELD
WHITEHAWK THERAPEUTICS INCWHWK$9.9M2,165,9977.28%+1.70pp3qHELD
ERASCA INCERAS$8.3M455,0006.12%+2.01pp2q+33.8%+$2.1M
TREVI THERAPEUTICS INCTRVI$7.7M414,0005.67%+1.98pp3qHELD
SUTRO BIOPHARMA INCSTRO$7.5M226,5755.52%+1.31pp2qHELD
TANGO THERAPEUTICS INCTNGX$7.2M230,2645.28%+1.69pp2qHELD
MBX BIOSCIENCES INCMBX$6.7M121,5244.92%+2.21pp3qHELD
PROTAGONIST THERAPEUTICS INCPTGX$6.5M53,0004.77%+0.60pp3qHELD
EDGEWISE THERAPEUTICS INCEWTX$5.4M133,0003.97%+0.84pp3qHELD
TANDEM DIABETES CARE INCTNDM$4.5M301,0003.33%-newNEW
DISC MEDICINE INCIRON$4.3M58,2503.13%+0.35pp3qHELD
SAVARA INCSVRA$3.7M605,2802.74%+0.27pp3qHELD
ARRIVENT BIOPHARMA INCAVBP$3.5M102,0002.60%-newNEW
INSMED INCINSM$3.0M28,4972.23%-1.25pp3qHELD
ACHIEVE LIFE SCIENCE INCACHV$3.0M462,3552.22%+1.20pp3qHELD
IDEAYA BIOSCIENCES INCIDYA$3.0M79,7002.18%+0.20pp2qHELD
OCULAR THERAPEUTIX INCOCUL$2.9M300,0002.16%+0.26pp2qHELD
AXSOME THERAPEUTICS INCAXSM$2.9M12,0002.16%-2.41pp3q-66.9%-$5.9M
DESIGN THERAPEUTICS INCDSGN$2.7M185,0001.96%-newNEW
UNITED THERAPEUTICS CORP DELUTHR$2.6M4,7501.89%-0.21pp3qHELD
SCHOLAR ROCK HLDG CORPSRRK$2.5M45,0001.82%+0.16pp3qHELD
IMMIX BIOPHARMA INCIMMX$2.4M230,4231.74%+0.18pp3qHELD
VIRIDIAN THERAPEUTICS INCVRDN$2.3M125,0001.69%-0.14pp2qHELD
MINERALYS THERAPEUTICS INCMLYS$2.3M84,1681.67%-newNEW
BRIGHT MINDS BIOSCIENCES INCDRUG$2.2M31,8131.64%-0.09pp2qHELD
TRAVERE THERAPEUTICS INCTVTX$2.2M39,0001.63%-0.39pp3q-57.1%-$3.0M
ZURA BIO LTDZURA$2.2M373,1281.62%-0.04pp2qHELD
ARTIVA BIOTHERAPEUTICS INCARTV$1.9M200,0001.42%-newNEW
NEKTAR THERAPEUTICSNKTR$1.9M26,9001.38%-0.07pp3qHELD
COMPASS THERAPEUTICS INCCMPX$1.7M771,0001.24%-0.74pp2q+54.2%+$593.5K
CABALETTA BIO INCCABA$1.6M505,4311.15%+0.14pp3qHELD
VERA THERAPEUTICS INCVERA$1.4M32,7001.03%+0.05pp3qHELD
EVOLUS INCEOLS$1.0M150,0000.76%-newNEW
CELCUITY INCCELC$418.5K4,0000.31%-0.03pp3qHELD
VYNE THERAPEUTICS INCVYNE$325.7K500,5510.24%+0.02pp3qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 96.1%Medical Devices 3.3%Other sectors 0.3%Not classified 0.2%
 
SectorValueShare
Biotech & Pharma$131.0M96.1%
Medical Devices$4.5M3.3%
Other sectors$418.5K0.3%
Not classified$325.7K0.2%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$136.2M35622357.4%44
Q1 2026$133.9M32910461.1%43
Q4 2025$103.3M27000068.5%49

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.